Skip to main content
Shannon Meeks, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

ShannonL.MeeksMD

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Coagulation Disorder Hematology

Professor of Pediatrics at Emory University School of Medicine; Program Director for Hemostasis and Thrombosis at Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta

Dr. Meeks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Meeks' full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Pediatrics, 2001 - 2004
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 2001

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2004 - 2025
  • VA State Medical License
    VA State Medical License 2001 - 2004
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a
    Shannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Severe Bleeding Events in Hemophilia _ Patients Receiving Emicizumab Prophylaxis
    Shannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Blood Coagulation: From Structure and Function to Therapeutics 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study Finds
    Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study FindsSeptember 9th, 2019
  • Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A Patients
    Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A PatientsAugust 29th, 2019

Grant Support

  • Mechanisms Of Immunogenicity Of Factor VIIINational Heart, Lung, And Blood Institute2010–2012

Hospital Affiliations